Patents by Inventor Terry LaCore

Terry LaCore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11026929
    Abstract: In various implementations, berberine metabolites, such as dihydroberberine and/or tetrahydroberberine, may be administered to manage blood glucose levels, increase ketone levels (e.g., blood concentration of ketones), and/or for therapeutic purposes in humans. The administration of a pharmaceutically effective amount of berberine metabolites, such as dihydroberberine, may reduce fasting blood glucose levels, improve glucose tolerance, and/or improve blood ketone response. In some implementations, berberine metabolites may be administered with one or more other compounds.
    Type: Grant
    Filed: May 6, 2019
    Date of Patent: June 8, 2021
    Assignee: Keto Patent Group, Inc.
    Inventors: Ryan Lowery, Jacob Wilson, Terry LaCore
  • Publication number: 20200129463
    Abstract: In various implementations, cannabidiol, beta-hydroxybutyrate, related compounds, and/or one or more other compounds may be administered to an individual to improve the health of the individual. Other compounds may include amino acids, short chain fatty acids, short chain triglycerides, medium chain fatty acids, medium chain triglycerides, long chain fatty acids, long chain triglycerides, berberine, metabolites of berberine (e.g., dihydroberberine), and/or combinations thereof.
    Type: Application
    Filed: October 29, 2019
    Publication date: April 30, 2020
    Inventors: Ryan Lowery, Jacob Wilson, Terry LaCore
  • Publication number: 20200118667
    Abstract: In various implementations, the system may facilitate the customization of nutritional products. The system may track sample(s) and allow testing of sample(s) in compliance with government and/or industry requirements (e.g., laws, regulations, and/or standards). The system may determine a core formulation based on DNA testing of a sample. The system may utilize the core formulation to create customized nutritional products. The system may monitor samples, testing, and/or orders (e.g., to inhibit unauthorized access to user information and/or to provide updates which may increase user satisfaction).
    Type: Application
    Filed: October 10, 2019
    Publication date: April 16, 2020
    Inventors: Terry LaCore, Michael Smith
  • Publication number: 20190255028
    Abstract: In various implementations, berberine metabolites, such as dihydroberberine and/or tetrahydroberberine, may be administered to manage blood glucose levels, increase ketone levels (e.g., blood concentration of ketones), and/or for therapeutic purposes in humans. The administration of a pharmaceutically effective amount of berberine metabolites, such as dihydroberberine, may reduce fasting blood glucose levels, improve glucose tolerance, and/or improve blood ketone response. In some implementations, berberine metabolites may be administered with one or more other compounds.
    Type: Application
    Filed: May 6, 2019
    Publication date: August 22, 2019
    Inventors: Ryan Lowery, Jacob Wilson, Shawn Wells, Terry LaCore
  • Patent number: 10278961
    Abstract: In various implementations, berberine metabolites, such as dihydroberberine and/or tetrahydroberberine, may be administered to manage blood glucose levels, increase ketone levels (e.g., blood concentration of ketones), and/or for therapeutic purposes in humans. The administration of a pharmaceutically effective amount of berberine metabolites, such as dihydroberberine, may reduce fasting blood glucose levels, improve glucose tolerance, and/or improve blood ketone response. In some implementations, berberine metabolites may be administered with one or more other compounds.
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: May 7, 2019
    Assignee: Keto Patent Group, Inc.
    Inventors: Ryan Lowery, Jacob Wilson, Shawn Wells, Terry LaCore
  • Publication number: 20170296520
    Abstract: In various implementations, berberine metabolites, such as dihydroberberine and/or tetrahydroberberine, may be administered to manage blood glucose levels, increase ketone levels (e.g., blood concentration of ketones), and/or for therapeutic purposes in humans. The administration of a pharmaceutically effective amount of berberine metabolites, such as dihydroberberine, may reduce fasting blood glucose levels, improve glucose tolerance, and/or improve blood ketone response. In some implementations, berberine metabolites may be administered with one or more other compounds.
    Type: Application
    Filed: April 19, 2017
    Publication date: October 19, 2017
    Inventors: Ryan Lowery, Jacob Wilson, Shawn Wells, Brian Underwood, Christopher N. Harding, Terry LaCore
  • Publication number: 20170296501
    Abstract: In various implementations, beta-hydroxybutyrate, related compounds, and/or one or more other compounds may be administered to an individual to cause weight loss, weight maintenance, elevate blood ketone levels, maintain blood ketone levels, reduce blood glucose levels, maintain blood glucose levels, improve energy, focus, mood, cognitive function, or aide with neurological or inflammatory disorders and/or combinations thereof. Other compounds may include short chain fatty acids, short chain triglycerides, medium chain fatty acids, medium chain triglycerides, long chain fatty acids, long chain triglycerides, berberine, metabolites of berberine (e.g., dihydroberberine), and/or combinations thereof.
    Type: Application
    Filed: April 19, 2017
    Publication date: October 19, 2017
    Inventors: Ryan Lowery, Jacob Wilson, Shawn Wells, Brian Underwood, Christopher N. Harding, Terry LaCore